Abera Bioscience AB Stock: price and insider trades · Sweden

Every trade that managers of Abera Bioscience AB disclose to Finansinspektionen is tracked on this page. Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.

Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €30k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €30k, bought by Mats Lundgren and made public on 22 July 2026 (0.24% of market cap).

Within a 30-day window, 1 purchase overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 22 July 2026, 87 days ago.

With 2 filings in twelve months, the company is quieter than the median of 7 filings across the 886 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.

Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.